Prolog Ventures LLC

Website Links

Description

A subsidiary of Sumitomo Corporation, Oxford is a specialty finance firm providing senior secured loans to public and private life science and healthcare services companies worldwide. For over 20 years, Oxford has delivered flexible financing solutions to its clients, enabling these companies to maximize their equity by leveraging their assets. In recent years, Oxford has originated over $ 1.5 billion in loans, with lines of credit ranging from $ 500 thousand to $ 40 million.

Founded in 1996 , Vivo Ventures is a healthcare investment firm focused on investing in and building high quality companies in the U.S. and China. With more than $1 billion under management, Vivo employs a unique multi-pronged strategy of identifying and working with companies with promising later development stage products in the U.S. and revenue stage companies in China. Vivo Ventures has offices in Palo Alto, California, Shanghai, China and Chengdu, China.

"Oxford is privileged to provide financing to support the continued development of AirXpanders' tissue expansion system," said Christopher A. Herr, managing director at Oxford Finance. "There is a tremendous market potential for the company's device and an opportunity to provide a more comfortable recovery process for individuals undergoing breast reconstruction.

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement, and performance solutions services help our customers to deliver better care to more people around the world at a lower cost.

Veran is a privately held image guided medical device company focused on developing the next standard of care for minimally invasive delivery of interventional oncology therapies. Veran provides proprietary 4-D registration capability for precise targeting of lesions via its FDA cleared platform. The Veran platform aims to reduce procedure time, reduce radiation exposure for the clinical staff, and increase targeting accuracy enabling physicians to cost effectively treat patients with reduced co-morbidity risk. Veran Medical Technologies is headquartered in St. Louis.

Companies nearby